首页> 美国卫生研究院文献>Journal of Virology >Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies
【2h】

Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies

机译:病毒样颗粒作为T细胞表位的载体:通过载体特异性抗体对T细胞启动的有限抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Virus-like particles (VLPs) are able to induce cytotoxic T-cell responses in the absence of infection or replication. This makes VLPs promising candidates for the development of recombinant vaccines. However, VLPs are also potent inducers of B-cell responses, and it is generally assumed that such VLP-specific antibodies interfere with the induction of protective immune responses, a phenomenon summarized as carrier suppression. In this study, we investigated the impact of preexisting VLP-specific antibodies on the induction of specific cytotoxic T-cell and Th-cell responses in mice. The data show that VLP-specific antibodies did not measurably reduce antigen presentation in vitro or in vivo. Nevertheless, T-cell priming was slightly reduced by antigen-specific antibodies; however, the overall reduction was limited and vaccination with VLPs in the presence of VLP-specific antibodies still resulted in protective T-cell responses. Thus, carrier suppression is unlikely to be a limiting factor for VLP-based T-cell vaccines.
机译:在没有感染或复制的情况下,病毒样颗粒(VLP)能够诱导细胞毒性T细胞应答。这使得VLP有望成为重组疫苗开发的候选者。但是,VLP也是B细胞反应的有效诱导剂,通常认为这种VLP特异性抗体会干扰保护性免疫反应的诱导,这种现象被概括为载体抑制。在这项研究中,我们调查了预先存在的VLP特异性抗体对小鼠中特异性细胞毒性T细胞和Th细胞应答的诱导作用。数据显示,VLP特异性抗体无法在体外或体内显着减少抗原呈递。然而,抗原特异性抗体可略微减少T细胞的启动。然而,总体减少是有限的,在存在VLP特异性抗体的情况下接种VLP仍会导致保护性T细胞应答。因此,载体抑制不太可能成为基于VLP的T细胞疫苗的限制因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号